Literature DB >> 2554804

Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity.

R N Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2554804      PMCID： PMC172727          DOI： 10.1128/AAC.33.9.1652

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.

Authors:  N E Allen; J N Hobbs; W E Alborn
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

2.  Effect of calcium on in vitro activity of LY146032 against Clostridium difficile.

Authors:  H Faruki; A C Niles; R L Heeren; P R Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

3.  Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci.

Authors:  J H Andrew; M C Wale; L J Wale; D Greenwood
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

5.  Nomenclature of LY146032.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

6.  In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; C Thauvin; B Gerson; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

7.  Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes.

Authors:  J H Lakey; M Ptak
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

8.  Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  A L Barry; G H Miller; C Thornsberry; R S Hare; R N Jones; R R Lorber; R Ferraresi; C Cramer
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191
  8 in total
  4 in total

1.  Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001.

Authors:  Ian A Critchley; Renée S Blosser-Middleton; Mark E Jones; Clyde Thornsberry; Daniel F Sahm; James A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

Authors:  R N Jones; M S Barrett; M E Erwin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerrin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.